de Miranda Cordeiro Frederico, Lemos Maria Betânia, Abe Ricardo Y, Maestrini Heloísa A, Guedes Guilherme B, Nascimento Marcelo M, Prata Tiago Santos
Glaucoma Instituto, Belo Horizonte, Minas Gerais, Brazil.
Hospital Medicina dos Olhos, Opty Group, Osasco, São Paulo, Brazil.
Lasers Med Sci. 2025 Sep 17;40(1):363. doi: 10.1007/s10103-025-04620-7.
We sought to investigate the influence of selective laser trabeculoplasty (SLT), as a primary treatment option, on long-term (between visits) intraocular pressure (IOP) variation parameters in eyes with ocular hypertension (OH) or open-angle glaucoma (OAG). This multicenter, real-world data based, retrospective study consecutively enrolled untreated patients that had undergone a single SLT treatment and had a minimum follow-up of 24 months post-SLT. All included patients had to have at least 3 IOP measurements before (within 90 days) the SLT procedure. Patients requiring any glaucoma medication or procedure during the follow-up were excluded. Main outcome measurements were the comparison between pre and post-SLT IOP variation parameters (mean, peak and IOP fluctuation), based on data collected from each follow-up visit. Among 835 patients that had undergone SLT between January 2011 and December 2020, 67 eyes from 67 patients (mean age, 60.5 ± 16.8 years) fulfilled all study inclusion/exclusion criteria and were included in the final analysis. After 24 months of follow-up, mean baseline IOP was significantly reduced from 19.1 ± 2.9 mmHg to 13.6 ± 2.1 following SLT (IOP change, 29%; p < 0.001). Regarding IOP variation parameters, mean baseline IOP peak was significantly reduced from 20.7 ± 3.5 mmHg to 15.1 ± 2.5 mmHg (IOP change, 27%; p < 0.001). In addition, mean baseline IOP fluctuation (based on within subject standard deviation values) was significantly reduced from 1.8 ± 0.1 mmHg to 1.2 ± 0.1 mmHg (IOP change, 33%; p < 0.001). Our results, derived from real world data, suggest that SLT not only effectively reduces mean IOP values, but also positively impacts (by approximately 30%) both IOP fluctuation and peak. Even though our findings provide additional support for the use of SLT on clinical practice, they certainly warrant confirmation by a prospective study.
我们试图研究选择性激光小梁成形术(SLT)作为一种主要治疗选择,对高眼压症(OH)或开角型青光眼(OAG)患者长期(就诊期间)眼压(IOP)变化参数的影响。这项基于多中心真实世界数据的回顾性研究连续纳入了接受单次SLT治疗且SLT术后至少随访24个月的未治疗患者。所有纳入患者在SLT手术前(90天内)必须至少进行3次眼压测量。排除随访期间需要任何青光眼药物或手术治疗的患者。主要观察指标是根据每次随访收集的数据,比较SLT术前和术后的眼压变化参数(平均值、峰值和眼压波动)。在2011年1月至2020年12月期间接受SLT治疗的835例患者中,67例患者的67只眼(平均年龄60.5±16.8岁)符合所有研究纳入/排除标准,被纳入最终分析。随访24个月后,SLT术后平均基线眼压从19.1±2.9 mmHg显著降至13.6±2.1 mmHg(眼压变化29%;p<0.001)。关于眼压变化参数,平均基线眼压峰值从20.7±3.5 mmHg显著降至15.1±2.5 mmHg(眼压变化27%;p<0.001)。此外,平均基线眼压波动(基于受试者内标准差)从1.8±0.1 mmHg显著降至1.2±0.1 mmHg(眼压变化3